DL-2-Methylglutamic acid - CAS 71-90-9
Catalog: |
BB034494 |
Product Name: |
DL-2-Methylglutamic acid |
CAS: |
71-90-9 |
Synonyms: |
2-Methyl-DL-glutamic acid |
IUPAC Name: | 2-amino-2-methylpentanedioic acid |
Description: | DL-2-Methylglutamic acid (CAS# 71-90-9) is a useful research chemical. |
Molecular Weight: | 161.16 |
Molecular Formula: | C6H11NO4 |
Canonical SMILES: | CC(CCC(=O)O)(C(=O)O)N |
InChI: | InChI=1S/C6H11NO4/c1-6(7,5(10)11)3-2-4(8)9/h2-3,7H2,1H3,(H,8,9)(H,10,11) |
InChI Key: | QHSCIWIRXWFIGH-UHFFFAOYSA-N |
Boiling Point: | 329.3±32.0 ℃ (Predicted) |
Melting Point: | 160 ℃ (dec.)(lit.) |
Purity: | ≥ 98.0 % (T) |
Density: | 1.336±0.06 g/cm3(Predicted) |
Appearance: | White crystal powder |
Storage: | Store at 2-8 ℃ |
MDL: | MFCD00149281 |
LogP: | 0.35350 |
Publication Number | Title | Priority Date |
US-2021261622-A1 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | 20200115 |
KR-20210091032-A | Long acting conjugate of Trigonal glucagon/GLP-1/GIP receptor agonist for use in the treatment of pulmonary disease | 20200113 |
WO-2021145552-A1 | Therapeutic use of long-acting conjugate of triple agonist having activity with respect to all of glucagon and glp-1 and gip receptors against lung disease | 20200113 |
KR-20210082120-A | A pharmaceutical composition for preventing or treating metabolic bone disorders, comprising GLP-2 or a conjugate thereof | 20191224 |
WO-2021133087-A1 | Pharmaceutical composition for preventing or treating metabolic bone diseases, comprising glp-2 or conjugate thereof | 20191224 |
PMID | Publication Date | Title | Journal |
17154243 | 20070101 | Characterization of 2-methylglyceric acid oligomers in secondary organic aerosol formed from the photooxidation of isoprene using trimethylsilylation and gas chromatography/ion trap mass spectrometry | Journal of mass spectrometry : JMS |
15938611 | 20050614 | Binding of C5-dicarboxylic substrate to aspartate aminotransferase: implications for the conformational change at the transaldimination step | Biochemistry |
11681981 | 20011102 | A tandem Michael addition ring-closure route to the metabotropic receptor ligand alpha-(hydroxymethyl)glutamic acid and its gamma-alkylated derivatives | The Journal of organic chemistry |
Complexity: | 179 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 161.06880783 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 161.06880783 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 101 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -3.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS